What alternative supportive therapies can be offered for a patient with acute sinusitis or cough when antibiotic criteria are not met, instead of the usual cough‑and‑cold combination, guaifenesin, and acetaminophen?

Alternative Supportive Therapies for Acute Sinusitis/Cough When Antibiotics Not Indicated

For viral rhinosinusitis or acute cough not meeting antibiotic criteria, offer nasal saline irrigation, NSAIDs (ibuprofen) for symptom relief, and intranasal corticosteroids, while avoiding oral phenylephrine and first-generation antihistamines. 1

Primary Supportive Therapies

First-Line Options

Nasal saline irrigation is the cornerstone of non-antibiotic management with low risk and demonstrated benefit. Higher volume irrigations (not just sprays) show superior efficacy in reducing nasal symptoms 1. This should be your go-to recommendation for all patients.

NSAIDs (ibuprofen, naproxen) effectively address malaise, sneezing, headache, and ear pain—but do NOT improve nasal discharge 1. Use with caution in older adults and those with renal/cardiovascular comorbidities.

Acetaminophen helps with nasal obstruction and rhinorrhea but does NOT relieve sore throat, malaise, sneezing, or cough 1. Choose based on the patient's predominant symptoms: NSAIDs for systemic symptoms, acetaminophen for nasal-specific complaints.

Second-Line Options

Intranasal corticosteroids can provide symptomatic relief with minimal risk, though evidence is modest (NNT = 13). Longer courses and higher doses show greater effect 1. This is particularly useful for post-viral rhinosinusitis lasting >10 days 2.

Topical oxymetazoline may help for 3-5 days maximum based on meta-analysis evidence, but you MUST warn patients about rebound congestion (rhinitis medicamentosa) if used beyond 3 days 1.

What to AVOID

Oral phenylephrine should NOT be used—the FDA advisory committee discouraged its use in 2023 based on multiple RCTs showing ineffectiveness 1.

First-generation antihistamines show no clinically significant effect on nasal obstruction, rhinorrhea, or sneezing and should be avoided in older adults 1. Even in younger patients, antihistamines alone lack efficacy except in select high-quality studies showing global symptom improvement 3.

Guaifenesin has mixed evidence at best—some studies show benefit for cough in adults, others do not 3. It is not a priority recommendation.

Clinical Algorithm

1. Start ALL patients on nasal saline irrigation (high volume preferred)
2. Add NSAIDs if patient has systemic symptoms (malaise, headache, body aches)
3. Add acetaminophen if nasal obstruction/rhinorrhea predominates
4. Consider intranasal corticosteroids if symptoms persist >5-7 days or are severe
5. Reserve topical oxymetazoline for severe nasal congestion, limit to 3 days maximum
6. Avoid oral phenylephrine, first-generation antihistamines, and routine guaifenesin

Important Caveats

The evidence for most symptomatic therapies is modest at best 4. Viral rhinosinusitis is self-limited, typically peaking at 3 days and resolving within 10-14 days 1. Discolored nasal discharge does NOT indicate bacterial infection—it reflects neutrophil presence from inflammation, not bacteria 1.

For cough specifically, evidence for non-antibiotic therapies is insufficient to make strong recommendations 4. Dextromethorphan may be effective based on limited data 3, but this is not a guideline-level recommendation.

Pseudoephedrine could be considered after 5 days if topical decongestants fail, but counsel patients about blood pressure/heart rate elevation and the difficulty obtaining this behind-the-counter medication 1.

The key is shared decision-making based on the patient's specific symptom profile, avoiding ineffective therapies, and setting realistic expectations about the self-limited nature of viral illness 1.